Changes in pERK1/2 and pAKT Expression in Melanoma Lesions After Imatinib Treatment
Melanoma Research - United States
doi 10.1097/cmr.0b013e3283046146
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)